Development asset linked to Santhera Pharmaceuticals Holding in public FDA and regional records.
pharma · Systemic Lupus Erythematosus
Santhera Pharmaceuticals Holding
Santhera Pharmaceuticals (Deutschland) GmbH
Santhera Pharmaceuticals Holding drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Pratteln, CH HQ
2004 Founded
115 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Pratteln, CH
- Founded
- 2004
- Employees
- 115
- Programs
- 2
- Drugs
- 1
- Patents
- 0
Santhera Pharmaceuticals Holding pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Santhera Pharmaceuticals Holding drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.